Extracutaneous features and complications of the Ehlers-Danlos syndromes: A systematic review

Introduction The Ehlers-Danlos syndromes (EDS) comprise a group of inherited connective tissue disorders presenting with variable fragility to skin, soft tissue, and certain internal organs, which can cause significant complications, particularly arterial rupture, bowel perforation and joint difficulties. Currently, there are 14 proposed subtypes of EDS, with all except one subtype (hypermobile EDS) having an identified genetic etiology. An understanding of the extracutaneous features and complications within each subtype is key to maximizing clinical care and reducing the risk of further complications. Methods A systematic review of EDS-related extracutaneous features and complications was undertaken. Results We identified 839 EDS cases that met the inclusion criteria. We noted a high prevalence of joint hypermobility amongst kyphoscoliotic (39/39, 100%), spondylodysplastic (24/25, 96.0%), and hypermobile (153/160, 95.6%) EDS subtypes. The most common musculoskeletal complications were decreased bone density (39/43, 90.7%), joint pain (217/270, 80.4%), and hypotonia/weakness (79/140, 56.4%). Vascular EDS presented with cerebrovascular events (25/153, 16.3%), aneurysm (77/245, 31.4%), arterial dissection/rupture (89/250, 35.5%), and pneumothorax/hemothorax. Chronic pain was the most common miscellaneous complication, disproportionately affecting hypermobile EDS patients (139/157, 88.5%). Hypermobile EDS cases also presented with chronic fatigue (61/63, 96.8%) and gastrointestinal complications (57/63, 90.5%). Neuropsychiatric complications were noted in almost all subtypes. Discussion Understanding the extracutaneous features and complications of each EDS subtype may help diagnose and treat EDS prior to the development of substantial comorbidities and/or additional complications. Systematic review registration https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022308151, identifier CRD42022308151.

[1]  N. Burrows,et al.  The role of cutaneous manifestations in the diagnosis of the Ehlers‐Danlos syndromes , 2022, Skin health and disease.

[2]  G. Larson,et al.  Alterations in glycosaminoglycan biosynthesis associated with the Ehlers-Danlos Syndromes. , 2022, American journal of physiology. Cell physiology.

[3]  M. Fehlings,et al.  Spinal manifestations of Ehlers-Danlos syndrome: a scoping review. , 2022, Journal of neurosurgery. Spine.

[4]  R. Wadia.  Periodontal Ehlers-Danlos syndrome. , 2020, British dental journal.

[5]  H. Critchley,et al.  Connecting brain and body: Transdiagnostic relevance of connective tissue variants to neuropsychiatric symptom expression , 2021, World journal of psychiatry.

[6]  P. Byers,et al.  The Ehlers–Danlos syndromes , 2020, Nature Reviews Disease Primers.

[7]  G. Calcagnini,et al.  A new insight on postural tachycardia syndrome in 102 adults with hypermobile Ehlers-Danlos Syndrome/hypermobility spectrum disorder. , 2020, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[8]  M. Ritelli,et al.  Molecular Genetics and Pathogenesis of Ehlers–Danlos Syndrome and Related Connective Tissue Disorders , 2020, Genes.

[9]  L. Au,et al.  Brittle cornea syndrome: current perspectives , 2019, Clinical ophthalmology.

[10]  J. Hoffman,et al.  Urogenital and pelvic complications in the Ehlers‐Danlos syndromes and associated hypermobility spectrum disorders: A scoping review , 2019, Clinical genetics.

[11]  M. Ritelli,et al.  Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes , 2019, Genes.

[12]  L. Opitz,et al.  Transcriptome Profiling of Primary Skin Fibroblasts Reveal Distinct Molecular Features Between PLOD1- and FKBP14-Kyphoscoliotic Ehlers–Danlos Syndrome , 2019, Genes.

[13]  E. Henske,et al.  The Genetics of Pneumothorax. , 2019, American journal of respiratory and critical care medicine.

[14]  D. Milewicz,et al.  Spontaneous pneumothorax and hemothorax frequently precede the arterial and intestinal complications of vascular Ehlers–Danlos syndrome , 2019, American journal of medical genetics. Part A.

[15]  M. Castori,et al.  Clinical Relevance of Joint Hypermobility and Its Impact on Musculoskeletal Pain and Bone Mass , 2018, Current Osteoporosis Reports.

[16]  J. Parisi,et al.  Bi-allelic Alterations in AEBP1 Lead to Defective Collagen Assembly and Connective Tissue Structure Resulting in a Variant of Ehlers-Danlos Syndrome. , 2018, American journal of human genetics.

[17]  Jinxiang Han,et al.  Osteogenesis imperfecta type III/Ehlers-Danlos overlap syndrome in a Chinese man. , 2018, Intractable & rare diseases research.

[18]  F. Malfait,et al.  Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review , 2017, Genetics in Medicine.

[19]  Stephen H. Bell,et al.  A ?scoping review. , 2018, Sexual health.

[20]  Ulrich Seidel,et al.  Biallelic COL3A1 mutations result in a clinical spectrum of specific structural brain anomalies and connective tissue abnormalities , 2017, American journal of medical genetics. Part A.

[21]  J. Belmont,et al.  The 2017 international classification of the Ehlers–Danlos syndromes , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[22]  A. Hakim,et al.  Cardiovascular autonomic dysfunction in Ehlers–Danlos syndrome—Hypermobile type , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[23]  P. Byers,et al.  Diagnosis, natural history, and management in vascular Ehlers–Danlos syndrome , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[24]  R. Engelbert,et al.  Disability in Adolescents and Adults Diagnosed With Hypermobility-Related Disorders: A Meta-Analysis. , 2016, Archives of physical medicine and rehabilitation.

[25]  R. Baron,et al.  Central sensitization as the mechanism underlying pain in joint hypermobility syndrome/Ehlers–Danlos syndrome, hypermobility type , 2016, European journal of pain.

[26]  G. Lauria,et al.  Small fiber neuropathy is a common feature of Ehlers-Danlos syndromes , 2016, Neurology.

[27]  B. Marinelli,et al.  Bone involvement in adult patients affected with Ehlers-Danlos syndrome. , 2016, Osteoporosis International.

[28]  Blair H. Smith,et al.  A classification of chronic pain for ICD-11 , 2015, Pain.

[29]  É. Mousseaux,et al.  The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers–Danlos syndrome , 2015, European Journal of Human Genetics.

[30]  P. McCrea,et al.  Nuclear signaling from cadherin adhesion complexes. , 2015, Current topics in developmental biology.

[31]  J. Van Oosterwijck,et al.  Evidence for central sensitization in patients with osteoarthritis pain: A systematic literature review , 2014, European journal of pain.

[32]  H. Yoshioka,et al.  Sp7/Osterix induces the mouse pro-α2(I) collagen gene (Col1a2) expression via the proximal promoter in osteoblastic cells. , 2014, Biochemical and biophysical research communications.

[33]  T. D. de Backer,et al.  Dysautonomia and its underlying mechanisms in the hypermobility type of Ehlers-Danlos syndrome. , 2014, Seminars in arthritis and rheumatism.

[34]  D. Milewicz,et al.  Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes. , 2014, Journal of vascular surgery.

[35]  R. Engelbert,et al.  Chronic pain in patients with the hypermobility type of Ehlers–Danlos syndrome: evidence for generalized hyperalgesia , 2015, Clinical Rheumatology.

[36]  K. Hankenson,et al.  Type III Collagen Regulates Osteoblastogenesis and the Quantity of Trabecular Bone , 2014, Calcified Tissue International.

[37]  K. Mannerkorpi,et al.  Profile of Cerebrospinal microRNAs in Fibromyalgia , 2013, PloS one.

[38]  Andy H. Choi,et al.  Current Perspectives , 2013, Journal of dental research.

[39]  Giorgio Cruccu,et al.  Reappraising neuropathic pain in humans—how symptoms help disclose mechanisms , 2013, Nature Reviews Neurology.

[40]  J. Clayton-Smith,et al.  Brittle cornea syndrome: recognition, molecular diagnosis and management , 2013, Orphanet Journal of Rare Diseases.

[41]  D. Eyre,et al.  Bone Collagen: New Clues to Its Mineralization Mechanism from Recessive Osteogenesis Imperfecta , 2013, Calcified Tissue International.

[42]  H. Kuniyasu,et al.  Respiratory complications of Ehlers-Danlos syndrome type IV. , 2013, Legal medicine.

[43]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[44]  W. Frishman,et al.  Vascular Ehlers-Danlos Syndrome: Pathophysiology, Diagnosis, and Prevention and Treatment of Its Complications , 2012, Cardiology in review.

[45]  M. Baumgartner,et al.  Phenotypic variability of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA): clinical, molecular and biochemical delineation , 2011, Orphanet journal of rare diseases.

[46]  H. Knoop,et al.  Both pain and fatigue are important possible determinants of disability in patients with the Ehlers-Danlos syndrome hypermobility type , 2011, Disability and rehabilitation.

[47]  D. Moher,et al.  Nonalcoholic Fatty Liver Disease and Acute Ischemic Stroke , 2010 .

[48]  A. Farmer,et al.  Unexplained gastrointestinal symptoms and joint hypermobility: is connective tissue the missing link? , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[49]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[50]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[51]  F. Schmidt.  Meta-Analysis , 2008 .

[52]  Teresa Foo,et al.  : SYSTEMATIC LITERATURE REVIEW , 2004 .

[53]  H. Calkins,et al.  Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. , 1999, The Journal of pediatrics.

[54]  S R Pinnell,et al.  Isolation of type III collagen from human adult parenchymal lung tissue. , 1977, Biochemistry.

[55]  M. Das,et al.  Ehlers-Danlos Syndrome , 2022, Neurocutaneous Disorders.